Bicistronic retroviral vectors for combining myeloprotection with cell-surface marking

Gene Therapy

Volumn 6, Issue 7, 1999, Pages 1222-1230

  Hildinger, M ^a   Schilz, A ^b   Eckert, H G ^b   Bohn, W ^a   Fehse, B ^c   Zander, A R ^c   Ostertag, W ^a   Baum, C ^a  

^a UNIVERSITY OF HAMBURG   (Germany)

^b BIONTECH AG   (Germany)

^c UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

Cell surface marker; Drug resistance gene; Hematopoietic cells; Retroviral vector

Indexed keywords

BETA ACTIN; CD34 ANTIGEN; CELL MARKER; COMPLEMENTARY DNA; MULTIDRUG RESISTANCE PROTEIN; NERVE GROWTH FACTOR RECEPTOR; VIRUS VECTOR;

ARTICLE; CANCER RESISTANCE; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; ENCEPHALOMYOCARDITIS VIRUS; FLOW CYTOMETRY; GENE EXPRESSION; GENETIC TRANSDUCTION; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; LYMPHOID CELL; PRIORITY JOURNAL; PROMOTER REGION; RETROVIRUS;

DRUG RESISTANCE, MULTIPLE; FLOW CYTOMETRY; GENE TRANSFER TECHNIQUES; GENETIC MARKERS; GENETIC VECTORS; HUMANS; P-GLYCOPROTEIN; POLYMERASE CHAIN REACTION; RECEPTOR, NERVE GROWTH FACTOR; RETROVIRIDAE; STEM CELLS; TUMOR CELLS, CULTURED;

ENCEPHALOMYOCARDITIS VIRUS; GALLUS GALLUS; UNIDENTIFIED RETROVIRUS;

EID: 0032804269     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gt.3300942     Document Type: Article

References (32)

1. Gottesman MM, Pastan I. Biochemistry of multidrug resistance mediated by the multidrug transporter. Ann Rev Biochem 1993; 62: 385-427.
2. Baum C et al. Gene transfer and transgene expression in hematopoietic cells. In: Strauss M, Barranger JA (eds). Concepts in Gene Therapy. DeGruyter: Berlin, 1997, pp 233-266.
3. Hanania EG et al. Results of MDR-1 vector modification trial indicate that granulocyte/macrophage colony-forming unit cells do not contribute to post-transplant hematopoietic recovery following intensive systemic therapy. Proc Natl Acad Sci USA 1996; 93: 15346-15351.
4. Devereux S et al. Feasibility of multidrug resistance (MDR-1) gene transfer in patients undergoing high-dose therapy and peripheral blood stem cell transplantation for lymphoma. Gene Therapy 1997; 5: 403-408.
5. Hesdorffer C et al. Phase I trial of retroviral-mediated transfer of the human MDR1 gene as marrow chemoprotection in patients undergoing high-dose chemotherapy and autologous stem-cell transplantation. J Clin Oncol 1998; 16: 165-172.
6. Baum C et al. Novel retroviral vectors for efficient expression of the multidrug resistance (mdr-1) gene in early hematopoietic cells. J Virol 1995; 69: 7541-7547.
7. Eckert HG et al. High-dose multidrug resistance in primary human hematopoietic progenitor cells transduced with optimized retroviral vectors. Blood 1996; 88: 3407-3415.
8. Hildinger M et al. Dominant selection of hematopoietic progenitor cells with retroviral MDR1-coexpression vectors. Hum Gene Ther 1998; 9: 33-42.
9. Fehse B et al. Impact of a new generation of gene transfer markers on gene therapy. Gene Therapy 1998; 5: 429-430.
10. Magni M et al. Induction of cyclophosphamide-resistance by aldehyde-dehydrogenase gene transfer. Blood 1996; 87: 1097-1103.
11. Zhao SC et al. Post-transplant methotrexate administration leads to improved curability of mice bearing a mammary tumor transplanted with marrow transduced with a mutant human dihydrofolate reductase cDNA. Hum Gene Ther 1997; 8: 903-909.
12. Scheffer GL et al. The drug resistance-related protein LRP is the human major vault protein. Nature Med 1995; 6: 578-582.
13. 6-alkylguanine-DNA-alkyltransferase. Blood 1996; 87: 1957-1961.
14. Rappa G, Lorico A, Flavell RA, Sartorelli AC. Evidence that the multidrug resistance protein (MRP) functions as a co-transporter of glutathione and natural product toxins. Cancer Res 1997; 57: 5232-5237.
15. Goodell MA et al. Dye efflux studies suggest that hematopoietic stem cells expressing low or undetectable levels of CD34 antigen exist in multiple species. Nature Med 1997; 3: 1337-1345.
16. Kim M, Cooper DD, Hayes SF, Spangrude GJ. Rhodamine-123 staining in hematopoietic stem cells of young mice indicates mitochondrial activation rather than dye efflux. Blood 1998; 91: 4106-4117.
17. Pawliuk R, Eaves CJ, Humphries RK. Sustained high-level reconstitution of the hematopoietic system by preselected hematopoietic cells expressing a transduced cell-surface antigen. Hum Gene Ther 1997; 8: 1595-1604.
18. + cells transduced with retroviral vectors containing an intracytoplasmatically truncated version of the human low-affinity nerve growth factor receptor (ALNGFR) gene. Hum Gene Ther 1997; 8: 1815-1824.
19. +)-restricted phenotypes of human hematopoietic progenitor cells by retrovirus-mediated gene transfer. Hum Gene Ther 1997; 8: 1611-1623.
20. Hildinger M et al. FMEV vectors: both retroviral long terminal repeat and leader are important for high expression in hematopoietic cells. Gene Therapy 1998; 5: 1575-1579.
21. Baum C et al. Cis-elements of Friend-SFFVp: role in disease induction and utility in retroviral vectors. Acta Haematol 1998; 99: 156-164.
22. Ghattas IR, Sanes JR, Majors JE. The encephalomyocarditis virus internal ribosomal entry site allows efficient coexpression of two genes from a recombinant provirus in cultered cells. Mol Cell Biol 1991; 11: 5848-5859.
23. Quitschke WW, Lin ZY, DePonti-Zilli L, Paterson BM. Beta actin promoter. High levels of transcription depend upon a CCAAT binding factor. J Biol Chem 1989; 264: 9539-9546.
24. Sorrentino BP, McDonagh KT, Woods D, Orlic D. Expression of retroviral vectors containing the human multidrug resistance 1 cDNA in hematopoietic cells of transplanted mice. Blood 1995; 86: 491-501.
25. Schilz AJ et al. High efficiency gene transfer to human hematopoietic SCID-repopulating cells under serum-free conditions. Blood 1998; 92: 3163-3171.
26. Sorrentino BP et al. Selection of drug-resistant bone marrow cells in vivo after retroviral transfer of human MDR1. Science 1992; 257: 99-103.
27. Podda S et al. Transfer and expression of the human multiple drug resistance gene into live mice. Proc Natl Acad Sci USA 1992; 89: 9676-9680.
28. Conneally E, Eaves CJ, Humphries RK. Efficient retroviral-mediated gene transfer to human cord blood stem cells with in vivo repopulating potential. Blood 1998; 91: 3487-3493.
29. Bunting KD et al. Transduction of murine bone marrow cells with an MDR1 vector enables ex vivo stem cell expansion, but these expanded grafts cause a myeloproliferative syndrome in transplanted mice. Blood 1998; 92: 2269-2279.
30. Aran JM, Gottesman MM, Pastan I. Drug-selected coexpression of human glucocerebrosidase and P-glycoprotein using a bicistronic vector. Proc Natl Acad Sci USA 1994; 91: 3176-3180.
31. Borman AM, Le Mercier P, Girard M, Kean KM. Comparison of picornaviral IRES-driven internal initiation of translation in cultured cells of different origins. Nucleic Acids Res 1997; 25: 925-932.
32. Emmerman M, Temin HM. Genes with promoters in retrovirus vectors can be independently suppressed by an epigenetic mechanism. Cell 1984; 39: 449-467.